MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives
MEI Pharma Explores Strategic Shifts, Leadership Changes
Express News | MEI Pharma Inc: Continuing to Conduct Certain Non-Clinical Activities Related to Co's Drug Candidate Assets
Express News | MEI Pharma Inc: Intended to Promptly Discontinue Clinical Development of Voruciclib
Express News | MEI Pharma Inc: Board Determined to Begin Evaluation of Strategic Alternatives
MEI Pharma Explores Strategic Options, Halts Drug Development